Analysis of in vitro lymphocyte proliferation as a screening tool for cellular immunodeficiency

Kelly D Stone1, Henry A Feldman, Charlotte Huisman

  • 1Division of Immunology, Children's Hospital Boston, Boston, MA 02115, USA.

Insights

Lymphocyte proliferation assays are useful for screening cellular immunodeficiency. However, concanavalin A (CONA) and tetanus toxoid (TT) were most effective, and the test is not a sensitive predictor of infection risk.

Area of Science:

  • Immunology
  • Clinical Diagnostics

Background:

  • Lymphocyte proliferation assays are standard for detecting cellular immunodeficiency.
  • Limited data exists on their screening performance across diverse patient groups.

Purpose of the Study:

  • To evaluate the effectiveness of lymphocyte proliferation assays as a screening tool for cellular immunodeficiency.
  • To compare the performance of different mitogens and antigens in identifying T cell dysfunction.

Main Methods:

  • Retrospective analysis of proliferation assays (1996-2003) using phytohemagglutinin (PHA), concanavalin A (CONA), pokeweed mitogen, tetanus (TT), and diphtheria (DT) toxoids.
  • Receiver operating characteristic (ROC) analysis comparing patients with T cell dysfunction to adult controls.
  • Correlation of assay results with clinical data.

Main Results:

  • Concanavalin A (CONA) demonstrated superior performance over phytohemagglutinin (PHA) in identifying immunodeficient patients.
  • Tetanus toxoid (TT) was the second most effective antigen.
  • Interpretation methods (raw counts, stimulation index, or simultaneous controls) showed equal performance.
  • Combining data from multiple stimulants did not improve assay performance.

Conclusions:

  • Lymphocyte proliferation testing is a valuable component of cellular immunodeficiency screening.
  • The assay's sensitivity in predicting immune compromise or opportunistic infection risk is limited.
  • CONA and TT are the most effective stimulants for this screening purpose.

Related Concept Videos